PALO ALTO, Calif., Nov. 16, 2017 /PRNewswire/ -- DNAmito,
Inc. (Palo Alto, CA) and
Varian Medical Systems (NYSE: VAR) announced today a development
and OEM agreement to integrate Prodecis into Varian's 360 Oncology™
care management software platform.
Prodecis will enable 360 Oncology to deliver genomics-based
evidence to help clinicians make more informed decisions.
Prodecis is a clinical-grade multifactor decision support system
integrating all currently available patient data to allow
personalized treatment of cancer. The predictive models based on
toxicity, tumor control, quality of life and cost effectiveness,
enhance the ability of 360 Oncology to provide the information
needed by a clinician to recommend the optimal individualized
treatment for each patient.
"Varian is committed to delivering cutting-edge technology that
helps ensure clinical decisions are made with the most complete
information available for the best cancer outcomes. Varian is
leveraging 360 Oncology as an enabling platform to allow its
partners, such as DNAmito, to provide its value-added services to
cancer treatment professionals," said Sukhveer Singh, vice president of Oncology
Continuum Solutions at Varian Medical Systems.
Dr. Philippe Lambin, co-inventor
and chief scientific advisor for DNAmito, added: "We are excited to
be selected by one of the world leaders in radiation oncology for
our multifactorial decision support system for cancer treatment. We
have shown that it is an essential tool for precision medicine.
Prodecis when combined with 360 Oncology can integrate various
types of medical data available as well as proprietary gene
signatures to support the choice of the best treatment."
The science behind the DNAmito platform is based on research
from Maastricht University. DNAmito
solutions provide genomics-based personalized analysis for
radio-sensitivity to optimize radiation treatment for cancer.
About DNAmito
DNAmito is led by its Co-founder and CEO, Syed Hamdani. It is headquartered in Palo
Alto, California, with significant presence
in Europe through the ptTheragnostic R&D office in
the Netherlands.
For more information about DNAmito, please
contact, info@dnamito.com.
About Varian
Varian Medical Systems focuses energy on saving lives and is the
world's leading manufacturer of medical devices and software for
treating and managing cancer. Headquartered in Palo Alto, California, Varian employs
approximately 6,600 people around the world. For more
information, visit http://www.varian.com and follow
@VarianMedSys on Twitter.
View original
content:http://www.prnewswire.com/news-releases/dnamito-inc-to-integrate-genomics-based-personalized-analysis-with-varians-oncology-care-management-software-platform-to-optimize-physicians-decisions-regarding-radiation-treatment-for-cancer-300557355.html
SOURCE DNAmito, Inc.